Search

Search Constraints

You searched for: Author/Creator Migden, Michael

Search Results

1. 428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs). (10th December 2020)